Skip links

Neonatal erythroderma & collodion

Project summary

The management of neonatal erythroderma is difficult group because this condition has many possible underlying causes. Many of the affected children experience a chronic benign course, but immunodeficiencies can lead to complications and death if not treated on time.

The main objective of the study is to find a definite diagnosis in a short time before complications occur. The best treatment can then start.

Impact

Through this study we hope to obtain more detailed information about patients with neonatal erythroderma and collodion babies that can help us finding a diagnosis fast, preferably within two weeks.

More detailed information

Principal Investigator:

Edwin Cuperus

Role Erasmus MC:

Coördinator of Partner

Department:

Project website:

Not available

Funding Agency:

Funding Agency